Ghana's Incas Diagnostics expects approval for COVID-19 antibody test

 KUMASI, Ghana (Reuters) - Ghana’s Incas Diagnostics expects the country’s regulator to approve its new COVID-19 antibody test by the end of July, saying its kits could help health authorities ease pandemic restrictions. 
 The company is also working with developers in Nigeria, Cameroon, South Africa and Senegal, with backing from the World Health Organization (WHO), on a mobile app that would help trace people potentially at high-risk of getting the virus. 

Comments